Back to top

stock-price-change: Archive

Zacks Equity Research

Recent Price Trend in Vertiv (VRT) is Your Friend, Here's Why

Vertiv (VRT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

VRTPositive Net Change

Zacks Equity Research

Analysts Estimate Preferred Bank (PFBC) to Report a Decline in Earnings: What to Look Out for

Preferred Bank (PFBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PFBCNegative Net Change

Zacks Equity Research

Pinnacle Financial (PNFP) Earnings Expected to Grow: Should You Buy?

Pinnacle Financial (PNFP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PNFPPositive Net Change

Zacks Equity Research

Analysts Estimate WaFd (WAFD) to Report a Decline in Earnings: What to Look Out for

WaFd (WAFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WAFDPositive Net Change

Zacks Equity Research

United Airlines (UAL) Expected to Beat Earnings Estimates: Should You Buy?

United (UAL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UALPositive Net Change DALPositive Net Change

Zacks Equity Research

Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for

Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WBAPositive Net Change

Zacks Equity Research

Interactive Brokers Group, Inc. (IBKR) Reports Next Week: Wall Street Expects Earnings Growth

Interactive Brokers (IBKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IBKRPositive Net Change

Zacks Equity Research

Omnicom (OMC) Earnings Expected to Grow: Should You Buy?

Omnicom (OMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OMCNegative Net Change

Zacks Equity Research

The PNC Financial Services Group, Inc (PNC) Expected to Beat Earnings Estimates: Should You Buy?

The PNC Financial Services Group (PNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PNCPositive Net Change

Zacks Equity Research

State Street Corporation (STT) Reports Next Week: Wall Street Expects Earnings Growth

State Street (STT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STTPositive Net Change WFCPositive Net Change

Zacks Equity Research

Earnings Preview: Bank of America (BAC) Q3 Earnings Expected to Decline

Bank of America (BAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BACPositive Net Change JPMPositive Net Change

Zacks Equity Research

FB Financial (FBK) Earnings Expected to Grow: Should You Buy?

FB Financial (FBK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FBKPositive Net Change

Zacks Equity Research

Hancock Whitney (HWC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Hancock Whitney (HWC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HWCPositive Net Change

Zacks Equity Research

Analysts Estimate Johnson & Johnson (JNJ) to Report a Decline in Earnings: What to Look Out for

Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JNJPositive Net Change

Zacks Equity Research

Analysts Estimate Citigroup (C) to Report a Decline in Earnings: What to Look Out for

Citigroup (C) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPositive Net Change BKPositive Net Change

Zacks Equity Research

Goldman Sachs (GS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Goldman (GS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GSPositive Net Change

Zacks Equity Research

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

NeoGenomics (NEO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

NEOPositive Net Change

Zacks Equity Research

Bears are Losing Control Over Agnico (AEM), Here's Why It's a 'Buy' Now

Agnico (AEM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

AEMNegative Net Change

Zacks Equity Research

DXP Enterprises (DXPE) is on the Move, Here's Why the Trend Could be Sustainable

DXP Enterprises (DXPE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

DXPENegative Net Change

Zacks Equity Research

Lands' End (LE) is on the Move, Here's Why the Trend Could be Sustainable

Lands' End (LE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

LENegative Net Change

Zacks Equity Research

Recent Price Trend in Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) is Your Friend, Here's Why

Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

ATATPositive Net Change

Zacks Equity Research

Here's What Could Help Ocular Therapeutix (OCUL) Maintain Its Recent Price Strength

Ocular Therapeutix (OCUL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

OCULNegative Net Change

Zacks Equity Research

Here's Why Momentum in Bridgewater (BWB) Should Keep going

Bridgewater (BWB) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

BWBNegative Net Change

Zacks Equity Research

Here's Why Carrefour (CRRFY) Is a Great 'Buy the Bottom' Stock Now

Carrefour (CRRFY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

CRRFYPositive Net Change

Zacks Equity Research

Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher

Staar Surgical (STAA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

STAAPositive Net Change